Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Asset Writedowns and Impairment (2020 - 2024)

Insight Molecular Diagnostics (IMDX) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with $36.9 million as the latest value for Q4 2024.

  • Quarterly Asset Writedowns and Impairment rose 922600.0% to $36.9 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $38.7 million through Dec 2024, up 472.1% year-over-year, with the annual reading at $14.6 million for FY2025, 65.16% down from the prior year.
  • Asset Writedowns and Impairment hit $36.9 million in Q4 2024 for Insight Molecular Diagnostics, up from -$4000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $36.9 million in Q4 2024 to a low of -$334000.0 in Q3 2020.
  • Historically, Asset Writedowns and Impairment has averaged $6.2 million across 3 years, with a median of $334000.0 in 2020.
  • Biggest YoY gain for Asset Writedowns and Impairment was 922600.0% in 2024; the steepest drop was 922600.0% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $334000.0 in 2020, then crashed by 101.2% to -$4000.0 in 2023, then soared by 922600.0% to $36.9 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for IMDX at $36.9 million in Q4 2024, -$4000.0 in Q4 2023, and $1.8 million in Q3 2023.